NCT01575470View on ClinicalTrials.gov

Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Traumatic Brain Injury
Interventions
BIOLOGICAL

autologous bone marrow mononuclear cells

bone marrow harvest (5ml/kg of body weight) performed within 36 hours of injury, followed by single intravenous infusion of bone marrow mononuclear cells.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT01575470 - Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells | Biotech Hunter | Biotech Hunter